Arena Pharmaceuticals Stock News

Shares of Arena Pharmaceuticals (NASDAQ:ARNA) decreased 19.4% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 15.75% over the past year to ($1.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) H.C.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Wells Fargo Securities 2020 Virtual Healthcare Conference September 09, 2020, 1:20 pm ET Executives Amit Munshi - Director, President, Chief Executive Officer

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on August 15, 2020, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to purch

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2020.

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its second quarter 2020 financial results and provide a corporate update on Wednesday, August 5, 2020, after the close of the U.S. financial mar

Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish, and continues to strengthen, amid recently receding volatility, writes...

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on July 15, 2020, the Compensation Committee of its Board of Directors granted to six new employees inducement stock options to purchase

Technically speaking, the U.S. benchmarks have registered a mid-July market whipsaw, writes Michael Ashbaugh, pressured at least briefly amid the month’s...

Ellis Investment Partners LLC purchased a new stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the second quarter, according to the company in its most recent filing with the Securities & Exchang

If you want to know who really controls Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), then you'll have to look at the...

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market